Your browser doesn't support javascript.
loading
An Anti-CD22-seco-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models.
Yu, Shang-Fan; Lee, Donna W; Zheng, Bing; Del Rosario, Geoffrey; Leipold, Douglas; Booler, Helen; Zhong, Fiona; Carrasco-Triguero, Montserrat; Hong, Kyu; Yan, Peter; Rowntree, Rebecca K; Schutten, Melissa M; Pillow, Thomas; Sadowsky, Jack D; Dragovich, Peter S; Polson, Andrew G.
Afiliação
  • Yu SF; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Lee DW; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Zheng B; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Del Rosario G; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Leipold D; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Booler H; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Zhong F; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Carrasco-Triguero M; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Hong K; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Yan P; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Rowntree RK; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Schutten MM; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Pillow T; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Sadowsky JD; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Dragovich PS; Research and Early Development, Genentech Inc., South San Francisco, California.
  • Polson AG; Research and Early Development, Genentech Inc., South San Francisco, California. polson@gene.com.
Mol Cancer Ther ; 20(2): 340-346, 2021 02.
Article em En | MEDLINE | ID: mdl-33273056
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Linfoma não Hodgkin / Imunoconjugados / Lectina 2 Semelhante a Ig de Ligação ao Ácido Siálico / Aminobenzoatos Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Linfoma não Hodgkin / Imunoconjugados / Lectina 2 Semelhante a Ig de Ligação ao Ácido Siálico / Aminobenzoatos Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article